SEC Form 4 · accession 0001704186-26-000006
Biohaven Ltd. · BHVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kimberly Gentile
Officer — SVP, Clinical Operations
Period of report
Sep 15, 2026
Accepted (ET)
Sep 17, 2026 · 6:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001935979
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F2,F1 | $12.34 | Sep 15, 2026 | A | 1,000 | A | — | Sep 15, 2036 | Common Shares | 1,000 | 1,000 | I |
Explanation of responses
- F1The shares underlying this option vest in four equal installments on September 15, 2026, 2027, 2028 and 2029, subject to the Reporting Person's son's continuous service with the Issuer at each vesting date.
- F2Represents a stock option granted to the Reporting Person's son in connection with the commencement of his employment with the Issuer. The Reporting Person disclaims beneficial ownership of all securities held by her son, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.